EIGER BIOPHARMACEUTICALS, INC. (NASDAQ: EIGR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR)
20 déc. 2022 12h30 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Eiger BioPharmaceuticals, Inc.? If so, please visit Eiger BioPharmaceuticals, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
DEADLINE ALERT for EIGR, TSP, and UIS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
20 déc. 2022 12h00 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 20, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, A LEADING NATIONAL FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
19 déc. 2022 12h33 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) between...
EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
16 déc. 2022 22h53 HE
|
Bragar Eagel & Squire
NEW YORK, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
DEADLINE ALERT for FIGS, EVA, EIGR, TSP: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
15 déc. 2022 11h00 HE
|
Law Offices of Howard G. Smith
BENSALEM, Pa., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
14 déc. 2022 16h12 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) between...
DEADLINE ALERT for EIGR, TSP, and UIS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
13 déc. 2022 12h02 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for EIGR, TSP, and UIS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
08 déc. 2022 12h15 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
EIGER BIOPHARMACEUTICALS, INC. (NASDAQ: EIGR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR)
06 déc. 2022 16h00 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Eiger BioPharmaceuticals, Inc.? If so, please visit Eiger BioPharmaceuticals, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
05 déc. 2022 12h38 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) between...